Whitepaper
18 Sep 2020

CPHI 2017_Pharma Insight Briefings

PDF 1.8 MB

Lucile Kowalsky, Project Manager in the New Product Introduction (NPI) department presented a case study during the Pharma Insight Briefings (CPHI Worldwide 2017) : "Quality by Design and Expertise:Accelerating time to market of complex oral solid dosage Accelerating time to market."

Content provided by our supplier

SKYEPHARMA PRODUCTION S.A.S

  • FR
  • 2017
    On CPHI since

Other Content from SKYEPHARMA PRODUCTION S.A.S (4)

  • News Skyepharma selects Veratrak platform to ensure secure data storing and sharing

    Using Veratrak's platform, the CDMO will have full oversight of data, including an audit trail of data and document processes
  • Whitepaper Recent development in complex tablet formulation design

    In this article, Mathieu Degomme, PharmD, Pharmaceutical Development Project Manager, and Aline Moulin, PhD, Pharmaceutical Development Director, both of Skyepharma, outline three case studies from recent early-stage development programmes to illustrate what kind of complex tablets can be developed to meet specific target dissolution profiles for versatile applications.
  • Brochure Company brochure

    Through 25 years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is a leader in the field of classic and complex oral solid dosage forms.
  • Brochure Skyepharma booklet of services

    We support our clients through the whole product value chain with expert teams involved at the very beginning of every project. - Pharmaceutical development services - Technology offer for complex oral solid forms - Analytical services - Manufacturing & packaging capabilities - Serialization & aggregation service ready